Major fraud cases in healthcare revealed this year

According to Fierce Pharma, Pfizer employee, who was later dismissed, had uploaded more than 12,000 documents to her personal Google Drive account as well as her own external storages. The data contained sensitive Pfizer files.

The employee’s case was taken to court. The impressive amount of stolen documents complicates the investigation which will concentrate on the foremost confidential information.

The employee appeared to behave suspiciously, as it was discovered that the laptop she presented was a misleading “evidence”, as well as her explanation about what she was going to use, for what reason and where it would be sent.

Pfizer fears external and treacherous headhunting, believing that competitors might instill an insider who would need to be tracked and detected, which is not an easy task.

The employee who violated the security policies at Pfizer was allegedly going to join Xencor. Xencor, Inc. refused to enter a dispute as it isn’t a party in the lawsuit.

Another case of aiding competitors has happened earlier in July this year. A former staffer at Genentech together with her husband admitted to having stolen trade secret to work for competitors. The company can request covering its financial losses from the violators via court, the sentence hasn’t been decided on yet.

Genentech has got its details on the number of proprietary drugs for curing serious diseases compromised. The Taiwanese enterprise called Eden Biologics is said to have been received the data for their own cheaper drug versions.

The story takes deeper roots and goes back to 2008 when the couple started to plan their own business and began their scheming by even hiring a third party to help them transfer the important data to some Taiwanese company and after to JHL, which they officially launched 3 years later.

The appropriated information alleviated the headache which hardly ever started for the couple: no time was spent on developing everything by themselves, no project designing from scratch thanks to the ready-made know-how and other procurements.

In 2016, Jordanov and Lin made a deal with Sanofi thanks to which the famous brand could produce and distribute a particular biosim in China. The brand not only paid over $100 million for the opportunity within the deal investing 80 million into the couple’s company.

Following the revelation JHL had to give up on the stolen projects and get rid of materials related to the case to settle it with Genentech. The name change was the second step.

Although the JHL was deprived of the products, Genentech has been going through rough times selling them experiencing a significant financial loss.



Managing behavioral risk, measuring employee morale, detecting corporate fraud and protecting your staff from blackmailers or undisciplined colleagues — moulding keys to healthy environment and data safety

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Alex Parfentiev

Leading Analyst at, I’m here to address those human factor risks many businesses often neglect or aren’t even aware of